Tenet Healthcare (THC) Stock Sinks As Market Gains: Here's Why
Tenet Healthcare (THC) closed the most recent trading day at $204.25, moving 1.22% from the previous trading session.
THC - Tenet Healthcare Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$259.50
DETAILS
HIGH:
$288.00
LOW:
$210.00
MEDIAN:
$262.50
CONSENSUS:
$259.50
UPSIDE:
27.05%
Stock News
3 Cheap Medical Stocks to Buy as US-Iran Tensions Keep Markets on Edge
U.S.-Iran tensions likely to lift demand for defensive plays, with Tenet Healthcare, Elevance Health and Aveanna Healthcare standing out as cheap medical stocks.
Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Why the Market Dipped But Tenet Healthcare (THC) Gained Today
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $208.82, denoting a +1.28% move from the preceding trading day.
Your Hospital’s HR Won’t Tell You This: Nurses Can Legally Shield $49,000 a Year by Stacking a 403(b) and a 457(b)
Your hospital's benefits packet lists a 403(b), and it may also quietly list a 457(b) on a separate page. Human resources rarely explains what happens when a nurse funds both: the IRS treats them as separate buckets, not one aggregate limit. That is the loophole. For nurses employed by nonprofit hospitals, public health systems, or... Your Hospital's HR Won't Tell You This: Nurses Can Legally Shield $49,000 a Year by Stacking a 403(b) and a 457(b)
What's Making Tenet Healthcare Stock Stand Out Right Now?
Tenet Healthcare Corporation THC is well-poised to grow, backed by the expanding adjusted admissions. Its solid Ambulatory Care segment performance is also a major tailwind.
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Tenet (THC) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Dow Taps Record as Nasdaq, Chips Pull Back
Stocks are trading mixed as chip stocks weigh and investors digest a fresh batch of June nonfarm payrolls data
Why the Market Dipped But Tenet Healthcare (THC) Gained Today
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $191.2, denoting a +2.2% move from the preceding trading day.
Beyond the Hospital Walls: Why USPI Is Becoming Tenet's Growth Engine
Tenet Healthcare is expanding its outpatient footprint through USPI, with strong first-quarter results and new ASC investments fueling long-term growth.
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Hospital Stocks Are Healing: 4 Names to Watch as Earnings Improve
The Zacks Medical-Hospital industry is adapting as care shifts beyond inpatient settings, demand rises and earnings outlook improves. THC, UHS, ACHC and CYH stand out.
Tenet Healthcare (THC) Ascends While Market Falls: Some Facts to Note
In the most recent trading session, Tenet Healthcare (THC) closed at $180.88, indicating a +1.19% shift from the previous trading day.
Tenet to Report Its Second Quarter 2026 Results on July 24
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its second quarter 2026 results before the market opens on Friday, July 24, 2026, to be followed by a conference call at 10:30 a.m. CT (11:30 a.m. Eastern Time).A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors.About Tenet HealthcareTenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company.
Tenet (THC) Upgraded to Buy: Here's Why
Tenet (THC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Tenet Healthcare (THC) Laps the Stock Market: Here's Why
Tenet Healthcare (THC) closed the most recent trading day at $179.11, moving +2.55% from the previous trading session.
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Price Targets
Tenet Healthcare price target lowered to $210 from $245 at Baird
$210.00
(was $185.35)
Robert W. Baird
Tenet Healthcare price target lowered to $238 from $257 at Barclays
$238.00
(was $185.35)
Andrew Mok
·
Barclays
Tenet Healthcare price target lowered to $260 from $275 at Stephens
$260.00
(was $183.27)
Scott Fidel
·
Stephens
Tenet Healthcare price target lowered to $254 from $260 at Morgan Stanley
$254.00
(was $183.95)
Morgan Stanley
Tenet Healthcare (THC) PT Raised to $283 at Guggenheim
$283.00
(was $234.58)
Jason Cassorla
·
Guggenheim
Tenet Healthcare price target raised to $270 from $240 at Truist
$270.00
(was $232.06)
Truist Financial
Tenet Healthcare price target raised to $265 from $229 at Wells Fargo
$265.00
(was $231.10)
Stephen Baxter
·
Wells Fargo
Tenet Healthcare price target raised to $271 from $257 at Guggenheim
$271.00
(was $232.26)
Guggenheim
Tenet Healthcare price target raised to $257 from $240 at Barclays
$257.00
(was $232.26)
Andrew Mok
·
Barclays
Tenet Healthcare price target raised to $288 from $260 at UBS
$288.00
(was $233.50)
UBS
Tenet Healthcare price target raised to $260 from $247 at Morgan Stanley
$260.00
(was $228.75)
Morgan Stanley
Tenet Healthcare price target raised to $277 from $253 at RBC Capital
$277.00
(was $226.35)
RBC Capital
Tenet Healthcare price target raised to $250 from $225 at KeyBanc
$250.00
(was $226.35)
Matthew Gillmor
·
KeyBanc
Tenet Healthcare price target raised to $253 from $252 at RBC Capital
$253.00
(was $194.98)
Ben Hendrix
·
RBC Capital
Tenet Healthcare price target lowered to $229 from $252 at Wells Fargo
$229.00
(was $208.24)
Wells Fargo
Tenet Healthcare price target raised to $247 from $232 at Morgan Stanley
$247.00
(was $195.02)
Craig Hettenbach
·
Morgan Stanley
Tenet Healthcare price target raised to $257 from $238 at Guggenheim
$257.00
(was $215.13)
Guggenheim
Tenet Healthcare price target raised to $240 from $229 at Barclays
$240.00
(was $186.68)
Andrew Mok
·
Barclays
Tenet Healthcare price target raised to $240 from $225 at Truist
$240.00
(was $200.74)
Truist Financial
Tenet Healthcare price target raised to $252 from $230 at RBC Capital
$252.00
(was $212.48)
RBC Capital